The Chinese MERIT study showed that premixed insulin combined with Met resulted in a greater reduction in HbA1c, less insulin consumption, less weight gain, a lower incidence of hypoglycemia, and lower cardiovascular risk than premixed insulin alone (15–17). The gene discussed is INS; the disease is Hypoglycemia.